SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-17-031312
Filing Date
2017-06-06
Accepted
2017-06-06 16:35:39
Documents
4
Period of Report
2017-05-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v468483_8k.htm 8-K 25387
2 EXHIBIT 2.1 v468483_ex2-1.htm EX-2.1 354575
3 EXHIBIT 99.1 v468483_ex99-1.htm EX-99.1 20157
4 GRAPHIC image_001.jpg GRAPHIC 5828
  Complete submission text file 0001144204-17-031312.txt   409684
Mailing Address 10210 CAMPUS POINT DRIVE, SUITE 150 SAN DIEGO CA 92121
Business Address 10210 CAMPUS POINT DRIVE, SUITE 150 SAN DIEGO CA 92121 (908) 864-4444
Sevion Therapeutics, Inc. (Filer) CIK: 0001035354 (see all company filings)

IRS No.: 841368850 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-31326 | Film No.: 17894527
SIC: 8731 Services-Commercial Physical & Biological Research